Selection of Bacillus anthracis isolates resistant to antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 424-428

  Athamna, A ^a   Athamna, M ^a,b   Abu Rashed, N ^a   Medlej, B ^a   Bast, D J ^c   Rubinstein, E ^b,d  

^a Triangle Research/Development Center   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Anthrax; Cross resistance; Macrolides; Quinolones

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GARENOXACIN; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS RESISTANCE; IN VITRO STUDY; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT MONITORING; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS;

EID: 4444309925     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh258     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. (2001). Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. MMWR Morbidity and Mortality Weekly Report 50, 973-6.
2. Centers for Disease Control and Prevention. (2001). Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. MMWR Morbidity and Mortality Weekly Report 50, 1014-6.
3. Inglesby, T. V., O'Toole, T., Henderson, D. A. et al. (2002). Anthrax as a biological weapon, 2002: updated recommendations for management. Journal of the American Medical Association 287, 2236-52.
4. Levy, S. B. (1998). Multidrug resistance: a sign of the times. New England Journal of Medicine 338, 1376-8.
5. Brook, I., Elliott, T. B., Pryor, H. I. et al. (2001). In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. International Journal of Antimicrobial Agents 18, 559-62.
6. Pomerantsev, A. P., Shishkova, N. A. & Marinin, L. I. (1992). Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16. Antibiotiki i Khimioterapiia 37, 31-4.
7. Price, L. B., Volger, A., Pearson, T. et al. (2003). In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrobial Agents and Chemotherapy 47, 2362-5.
8. Chen, Y., Succi, J., Tenover, F. C. et al. (2003). β-Lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. Journal of Bacteriology 185, 823-30.
9. Mohammed, M. J., Marston, C. K., Popovic, T. et al. (2002). Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. Journal of Clinical Microbiology 40, 1902-7.
10. National Committee for Clinical Laboratory Standards (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
11. Choe, C. H., Bouhauala, S., Brook, I. et al. (2000). In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis. Antimicrobial Agents and Chemotherapy 44, 1766.
12. Bryskier, A. (2002). Bacillus anthracis and antibacterial agents. Clinical Microbiology and Infectious Diseases 8, 467-78.
13. Cavallo, J. D., Ramisse, F., Girardet, M. et al. (2002). Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Antimicrobial Agents and Chemotherapy 46, 2307-9.
14. Òdendaal, M. W., Pieterson, P. M., de Vos, V. et al. (1991). The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. Onderstepoort Journal of Veterinary Research 58, 17-9.
15. Volger, A. J., Busch, J. D., Percy-Fine, S. et al. (2002). Molecular analysis of rifampicin resistance in Bacillus anthracis and Bacillus cereus. Antimicrobial Agents and Chemotherapy 46, 511-3.